Search
Jan 10, 2023
A biotech veteran gives his take on volatile times and allo CAR-T.
Arie Belldegrun talks about navigating tough times during biotech downturns and allogeneic CAR-T.
Jan 9, 2023
TCR therapies as a new modality in cancer treatment
Immunocore's Bahija Jallal talks about TCR based therapies at #JPM23.
Jan 9, 2023
Luke Timmerman at #JPM23
Luke Timmerman fills us in on the latest at the Timmerman Report and his upcoming climb for cancer research of Mount Kilimanjaro at #JPM23.
Jan 9, 2023
Beam's Therapeutics' John Evans talks base editing at #JPM23
John Evans talks about base editing as a tool for genetic diseases and cell therapy engineering.
Jan 9, 2023
How a16z invests in healthcare
Jorge Conde tells us about a16z's philosophy for investing in healthcare at #JPM23.
Jan 9, 2023
Noubar Afeyan discusses the year ahead
Flagship Pioneering’s Noubar Afeyan gives his take on the biotech sector for the year ahead at #JPM23.
Jan 9, 2023
Kicking off #JPM23 with Brian Skorney
R.W. Baird Senior Research Analyst Brian Skorney speaks first with BiotechTV on the Monday morning JPM23.
Jun 21, 2022
Noubar Afeyan on Moderna and Biotech Innovation
Flagship Pioneering's Noubar Afeyan describes what it was like to navigate the pandemic as Chairman of Moderna.
.png){kind=logo}
